People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,565.00GBp
19 Dec 2014
Price Change (% chg)

-7.50p (-0.16%)
Prev Close
4,572.50p
Open
4,612.50p
Day's High
4,617.00p
Day's Low
4,511.50p
Volume
3,115,469
Avg. Vol
2,676,734
52-wk High
4,946.41p
52-wk Low
3,367.07p

Search Stocks

Berger, Genevieve 

Brief Biography

Professor Genevieve Berger has been appointed as Non-Executive Director of AstraZeneca Plc., effective April 26, 2012. Geneviève Berger is Chief Science Officer at Unilever PLC and a member of the Unilever Leadership Executive. She holds three doctorates – in physics, human biology and a medical doctorate. She was appointed Professor of Medicine at Université Pierre et Marie Curie, Paris in 2006. From 2003 to 2008 she was Professor and Hospital Practitioner at l’Hôpital de la Pitié-Salpêtrière, Paris. Previous positions she has held include Director of the Biotech and Agri-Food Department, then Head of the Technology Directorate at the French Ministry of Research and Technology (1998-2000); Director General, Centre National de la Recherche Scientifique (2000-2003); and Chairman of the Health Advisory Board of the EU Commission (2006-2008). She was a non-executive board member of Unilever from 2007 to 2008 before being appointed to her current position and was a Non-Executive Director of Smith & Nephew plc from 2010 to 2012.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leif Johansson

540,000

Pascal Soriot

3,344,000

Marc Dunoyer

296,000

Ruud Dobber

--

Caroline Hempstead

--

Paul Hudson

--
As Of 30 Dec 2013
Search Stocks